Avinger atherectomy devices

images avinger atherectomy devices

To listen to a live webcast, please visit the investor relations section of the Avinger web site at www. Clair Shores, Mich. The primary safety endpoint was major adverse events MAEs at 30 days, including all-cause mortality, major amputation in the target limb or TLR. Technology Atherectomy Devices January 16, This further confirms the effectiveness and versatility of directional atherectomy in a wide range of vessel sizes and clinical presentations. Condensed Balance Sheets. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially.

  • Avinger’s ImageGuided Atherectomy Device Cleared by FDA FDANews
  • Avinger’s ImageGuided Atherectomy Device Cleared by FDA FDANews
  • Avinger announces (k) filing of Pantheris Small Vessel device Interventional News
  • Update on Atherectomy System Technology DAIC
  • Pantheris™ Deborah

  • Avinger’s ImageGuided Atherectomy Device Cleared by FDA FDANews

    Onboard image-guided atherectomy Used in conjunction with other medical devices used in cath lab procedures. Compatible with Sled. First ever image-guided atherectomy device. Learn More · logo-ocelot_v2.

    Avinger’s ImageGuided Atherectomy Device Cleared by FDA FDANews

    State of the art image-guided CTO crossing device. Learn More. logo-lightbox_v2. Avinger announces the US FDA clearance of the Pantheris SV, a small vessel atherectomy system for peripheral arterial disease.
    Feedback from the field continues to be excellent, with clinical results, product reliability and case volume all tracking positively for the next generation device. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially.

    Technology Atherectomy Devices January 16, Pantheris SV uses a combination of directional atherectomy with onboard image-guidance to provide several potential clinical advantages, including an enhanced safety profile, the ability to maximize luminal gain without causing vascular injury, and precise vessel measurement capabilities.

    Feldman, Stevan I. Contact Us.

    Avinger announces (k) filing of Pantheris Small Vessel device Interventional News

    images avinger atherectomy devices
    Avinger atherectomy devices
    In MayVolcano Corp. News Atherectomy Devices April 04, Cost of revenue. Current assets:. Following our anticipated limited launch of Pantheris SV, we plan on leveraging our growing commercial infrastructure and installed base of Lumivascular accounts to efficiently scale up the introduction of Pantheris SV and drive growth of our Pantheris product family in the second half of Condensed Balance Sheets.
    Pantheris SV, a product line extension of Avinger's Lumivascular image-guided atherectomy platform, is expected to expand the available.

    Update on Atherectomy System Technology DAIC

    Vascular disease device maker Avinger said it received FDA (k) line of image-guided, catheter-based atherectomy devices to treat. based company's lumivascular image-guided atherectomy platform which it hopes will expand the available market for its Pantheris devices by.
    Matt Kreps. Register Sign In. Pantheris SV uses a combination of directional atherectomy with onboard image-guidance to provide several potential clinical advantages, including an enhanced safety profile, the ability to maximize luminal gain without causing vascular injury, and precise vessel measurement capabilities.

    Cost of revenue. This debulking of lesions is often performed in vessels where plaque burden is especially heavy and difficult to treat with angioplasty, including chronic total occlusions and heavily calcified lesions.

    Pantheris™ Deborah

    Total stockholders' equity deficit. Three Months Ended.

    images avinger atherectomy devices
    Avinger atherectomy devices
    Net loss per share attributable to common stockholders basic and diluted.

    Avinger is based in Redwood City, California. We continued to build our sales organization in the fourth quarter and expect to increase sales headcount in as we scale utilization and drive revenue growth.

    Video: Avinger atherectomy devices

    News Atherectomy Devices April 04, PAD is estimated to affect over 12 million people in the U. Matt Kreps. December 31.

    3 Replies to “Avinger atherectomy devices”
    1. The transaction included the JetStream atherectomy system, which is unique in that it uses a drill bit-like catheter tip and a set of foldout side-cutting blades to debulk lesions.

    2. Following our anticipated limited launch of Pantheris SV, we plan on leveraging our growing commercial infrastructure and installed base of Lumivascular accounts to efficiently scale up the introduction of Pantheris SV and drive growth of our Pantheris product family in the second half of The vendors in the chart include:.